Towa Pharmaceutical Co (JP:4553) has released an update.
Towa Pharmaceutical Co., Ltd. reports a positive financial performance for Q1 2024, with net sales and operating profit increasing by 14.7% and 38.5% respectively. The company’s profit attributable to owners jumped by 15.7%, and a forecast suggests continued revenue growth but a dip in profits for the year-end. No changes in significant subsidiaries have occurred, and there’s been a revision in accounting policies as per new regulations.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
